🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
What Comes After Fulvestrant? A Real World Multicenter Retrospective Study-...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2017-10-10
Trial ID
NCT03541863
This study is a multicenter, prospective, randomized, open-label clinical s...
Status
Recruiting
Location
Fujian Cancer Hosptial
Start Date
2026-01-21
Trial ID
NCT07581834
This is a Phase III, multisite exploratory study for women ≥ 65 years of ag...
Status
Recruiting
Location
Yale University
Start Date
2024-07-19
Trial ID
NCT06507618
Treatments Being Tested
This study will evaluate the efficacy and safety of inavolisib in combinati...
Status
Recruiting
Location
Banner Health MD Anderson AZ
Start Date
2023-09-08
Trial ID
NCT05894239
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Status
Recruiting
Location
Ellison Clinic at Saint John's
Start Date
2023-04-17
Trial ID
NCT05768139
The objective of this trial, DBCG R25, will be to evaluate the effect of tr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT06585969
Treatments Being Tested
PATRICIA is a phase II, open-label, multicentre, Simon's two-stage-design s...
Status
Completed
Location
ICO-Badalona
Start Date
2015-07
Trial ID
NCT02448420
Treatments Being Tested
This is an open label, multicenter, single arm phase II study to evaluate t...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-09-13
Trial ID
NCT05467891
Treatments Being Tested
This was an open label, multi-center protocol for U.S. patients enrolled in...
Status
Completed
Location
Arizona Oncology Associates PC- HAL
Start Date
2017-06-20
Trial ID
NCT03078751
Treatments Being Tested
Although randomized controlled trials (RCTs) provide evidence of efficacy, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-03-15
Trial ID
NCT02753686